6 completed, 1 active not recruiting, 1 recruiting. 3 Phase 3, 2 Phase 2, 2 Phase 4, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow green tea extract polyphenone E: new trials by email Literature Review of green tea extract polyphenone E trials Research Report on green tea extract polyphenone E
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis Topical treatment - Actinic Keratosis of Face and Scalp | Phase 3 | Recruiting | Aresus Pharma GmbH | 280 | 2024-09-04 | 2025-08-22 |
| To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration - Prostate Carcinoma | Phase 2 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 360 | 2021-10-05 | 2026-09-04 |
| Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males electrocoagulation, cidofovir 1% topical ointment, sinecatechins 10% topical ointment - High-grade Anal Intraepithelial Neoplasia | Phase 3 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 108 | 2020-09-18 | 2024-07-10 |
| Investigating Veregen ™ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study Veregen only, Cryotherapy and Veregen - Verruca, Warts | Phase 4 | Completed | University of Texas Southwestern Medical Center | 28 | 2015-07-01 | 2017-09-08 |
| Topical Green Tea Ointment in Treatment of Superficial Skin Cancer Sinecatechins 10%, Placebo - Carcinoma, Basal Cell | Phase 2 / Phase 3 | Completed | Maastricht University Medical Center | 42 | 2014-11-01 | 2016-05-18 |
| Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers Veregen, Green Tea - Anogenital Warts | Phase 1 | Completed | MediGene | 30 | 2011-12-01 | 2012-04-19 |
| Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment Sinecatechins 15% Ointment, Cryotherapy alone - External Genital Warts | Not applicable | Completed | Icahn School of Medicine at Mount Sinai | 42 | 2011-09-01 | 2019-06-14 |
| Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage Polyphenon E (Veregen) 15% ointment, Green Tea Beverage with defined catechin content - Genital Warts, Perianal Warts | Phase 4 | Completed | MediGene | 43 | 2010-01-01 | 2010-09-08 |
Condylomata Acuminata (2) · Carcinoma, Basal Cell (1) · Keratosis, Actinic (1) · Prostatic Neoplasms (1) · Warts (1)
MediGene (2) · Aresus Pharma GmbH (1) · ECOG-ACRIN Cancer Research Group (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Icahn School of Medicine at Mount Sinai (1) · Maastricht University Medical Center (1) · University of Texas Southwestern Medical Center (1)
Germany (3) · United States (3) · Guam (1) · Netherlands (1) · Puerto Rico (1) · Spain (1)
Frank Wagner, Md, PD (1) · Gary Goldenberg, MD (1) · Nagi B Kumar (1) · Nicole WJ Kelleners-Smeets, MD, PhD (1)
UG1CA189828 (1)